Drug intelligence / Profile preview

Convalescent Plasma-Maranatha Christian University-COVID-19

Development stage
Unknown
Lead developer
Maranatha Christian University
Modality
Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

Convalescent Plasma-Maranatha Christian University-COVID-19 refers to a specific convalescent plasma therapy evaluated by researchers at Maranatha Christian University in Indonesia. This biologic therapy utilizes plasma collected from individuals who have recovered from COVID-19, which contains high titers of polyclonal neutralizing antibodies (specifically 1:320 in the studied cohort) against the SARS-CoV-2 virus. The treatment is administered intravenously to provide passive immunization, aiming to neutralize the virus and prevent the progression of severe disease in hospitalized, non-intubated patients. It has been utilized under emergency approval in Indonesia as part of a broader multicenter clinical evaluation.

Other names
Convalescent Plasma TherapyCPT
02

Targets

RBD (SARS-CoV-2 spike receptor-binding domain)S2 (SARS-CoV-2 spike S2 subunit)S1-NTD (SARS-CoV-2 spike S1 N-terminal domain)

Beyond the preview

Go deeper on Convalescent Plasma-Maranatha Christian University-COVID-19.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Convalescent Plasma-Maranatha Christian University-COVID-19.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call